Expertise in
1
conditions

Ulf Petrausch

Zuerich (kreis 7) / Hirslanden, ZH, CH 
Expertise in
1
conditions
Zuerich (kreis 7) / Hirslanden, ZH, CH 

Overview

Ulf Petrausch practices practicing medicine in Zuerich (kreis 7) / Hirslanden, Switzerland.

Petrausch is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Mesothelioma, Bladder Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Lymphadenectomy.

They are actively involved in clinical research, co-authoring 47 peer reviewed articles and participating in 4 clinical trials.

Locations

Zuerich (kreis 7) / Hirslanden, ZH, Switzerland
Other Locations
Zurich, ZH, Switzerland
Bern, BE, Switzerland
Cham, ZG 6330, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Intravesical Recombinant BCG (Bacillus Calmette Guérin) Followed by Perioperative Chemo-immunotherapy for Patients With Muscle-invasive Bladder Cancer (MIBC). A Multicenter, Single-arm Phase II Trial
Intravesical Recombinant BCG (Bacillus Calmette Guérin) Followed by Perioperative Chemo-immunotherapy for Patients With Muscle-invasive Bladder Cancer (MIBC). A Multicenter, Single-arm Phase II Trial
Enrollment Status: Active_not_recruiting
Publish Date: January 21, 2026
Intervention Type: Drug
Study Drugs: Recombinant intravesical BCG, Atezolizumab, Cisplatin, Gemcitabine
Study Phase: Phase 2
Neoadjuvant and Adjuvant Durvalumab in Combination With Neoadjuvant Chemotherapy in Patients With Operable Urothelial Cancer. A Multicenter, Single-arm Phase II Trial
Neoadjuvant and Adjuvant Durvalumab in Combination With Neoadjuvant Chemotherapy in Patients With Operable Urothelial Cancer. A Multicenter, Single-arm Phase II Trial
Enrollment Status: Completed
Publish Date: May 04, 2025
Intervention Type: Drug
Study Drug: Durvalumab
Study Phase: Phase 2
Named Patient Use Program to Provide Abemaciclib for the Treatment of Metastatic Breast Cancer
Named Patient Use Program to Provide Abemaciclib for the Treatment of Metastatic Breast Cancer
Enrollment Status: Approved_for_marketing
Publish Date: December 16, 2024
Intervention Type: Drug
Efficacy of the Consilium Smartphone App for Detecting Symptoms and Treatment Side Effects in Cancer Patients Depending on Form of Medication Application, Age and Outpatient Characteristics: Observational Study
Efficacy of the Consilium Smartphone App for Detecting Symptoms and Treatment Side Effects in Cancer Patients Depending on Form of Medication Application, Age and Outpatient Characteristics: Observational Study
Enrollment Status: Terminated
Publish Date: February 01, 2022
Intervention Type: Device
View 3 Less Clinical Trials

47 Total Publications

Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase 2 Trial SAKK 06/19.
Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase 2 Trial SAKK 06/19.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 29, 2026

Frequently Asked Questions about Ulf Petrausch

Is Ulf Petrausch a top-rated expert for Mesothelioma?

MediFind is an objective health platform that identifies experts based on real-world data. Ulf Petrausch is classified as an Advanced expert for Mesothelioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ulf Petrausch participate in research or clinical trials?

Yes. Ulf Petrausch has published 47 articles and abstracts on conditions like Mesothelioma. You can view a list of Ulf Petrausch's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Petrausch's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile